Ataxia Telangiectasia Mutated (ATM) Signaling Network Is Modulated by a Novel Poly(ADP-ribose)-dependent Pathway in the Early Response to DNA-damaging Agents
Open accessThe DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Poly(ADP-ribosyl)ation is a post-translational modification that is instantly stimulated by DNA strand breaks creating a unique signal for the modulation of protein functions in DNA repair and cell cycle checkpoint pathways. Here we report that lack of poly(ADP-ribose) synthesis leads to a compromised response to DNA damage. Deficiency in poly(ADP-ribosyl)ation metabolism induces profound cellular sensitivity to DNA-damaging agents, particularly in cells deficient for the protein kinase ataxia telangiectasia mutated (ATM). At the biochemical level, we examined the significance of poly(ADP-ribose) synthesis on the regulation of early DNA damage-induced signaling cascade initiated by ATM. Using potent PARP inhibitors and PARP-1 knock-out cells, we demonstrate a functional interplay between ATM and poly(ADP-ribose) that is important for the phosphorylation of p53, SMC1, and H2AX. For the first time, we demonstrate a functional and physical interaction between the major DSB signaling kinase, ATM and poly(ADP-ribosyl)ation by PARP-1, a key enzyme of chromatin remodeling. This study suggests that poly(ADP-ribose) might serve as a DNA damage sensory molecule that is critical for early DNA damage signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This finding is consistent with published studies in which loss of MRN (2), Tip60 (4, 6), or acute PARP inhibition (35) led to defective activation of ATM's kinase activity.”
From DNA double-strand breaks promote methylation of histone H3 on lysine 9 and transient formation of repressive chromatin (2014) · cites this paper as [35]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Finally, depletion of suv39h1 increased cell sensitivity to PARPi (Fig. 6D), consistent with previous reports that cells lacking ATM are sensitive to PARP inhibition (34,35).”
From DNA double-strand breaks promote methylation of histone H3 on lysine 9 and transient formation of repressive chromatin (2014) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Cytoprotective membrane-permeable peptides designed from the Bax-binding domain of Ku70
Sawada, M., Hayes, P., & Matsuyama, S. (2003) · Nature Cell Biology · doi:10.1038/ncb955 · Cited by 161
RetractedTargeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
McCabe, N., Turner, N. C., Lord, C. J., Kluzek, K., Białkowska, A., Swift, S., Giavara, S., O'Connor, M. J., Tutt, A. N., Zdzienicka, M. Z., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0140 · Cited by 1,310
Post‐translational modifications and activation of p53 by genotoxic stresses
Appella, E., & Anderson, C. W. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02225.x · Cited by 1,079
Poly(ADP-ribosyl)ation by PARP-1: `PAR-laying' NAD+ into a nuclear signal
Kim, M. Y., Zhang, T., & Kraus, W. L. (2005) · Genes & Development · doi:10.1101/gad.1331805 · Cited by 802
Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.
Wang, Z. Q., Auer, B., Stingl, L., Berghammer, H., Haidacher, D., Schweiger, M., & Wagner, E. F. (1995) · Genes & Development · doi:10.1101/gad.9.5.509 · Cited by 774
Direct Activation of the ATM Protein Kinase by the Mre11/Rad50/Nbs1 Complex
Lee, J.-H., & Paull, T. T. (2004) · Science · doi:10.1126/science.1091496 · Cited by 762
Cited by
Items 101–200 of 290
Poly(ADP-Ribose) Polymerases in Plants and Their Human Counterparts: Parallels and Peculiarities
Rissel, D., & Peiter, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071638 · Cited by 57
“Additionally, PARP1 was implied to be involved in homologous recombination (HR) repair of DNA double strand breaks (DSB), since components of the HR machinery such as MRE11 (mitotic recombination 11) and ATM (ataxia telangiectasia-mutated) are rapidly recruited to DNA damage sites in a poly(ADP-ribose)-dependent manne…”
BackgroundThe Actin Depolymerizing Factor (ADF)/Cofilin Signaling Pathway and DNA Damage Responses in Cancer
Chang, C., Leu, J., & Lee, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16024095 · Cited by 58
“Inhibition of PARP1 reduces ATM activity and DNA repair capacity, and it has been considered for design of cancer radiotherapeutic strategy [113,114].”
BackgroundFilia Is an ESC-Specific Regulator of DNA Damage Response and Safeguards Genomic Stability
Zhao, B., Zhang, W., Duan, Y.-L., Lu, Y., Cun, Y., Li, C., Guo, K., Nie, W., Li, L., Zhang, R., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.03.017 · Cited by 58
“For instance, PARP1- or PAR-deficient cells are compromised in ATM activation, DNA damage signaling, cell-cycle checkpoints, and DNA repair (Aguilar-Quesada et al., 2007; Haince et al., 2007; Min et al., 2013).”
Hu, X., Zhang, J., Zhang, Y., Jiao, F., Wang, J., Chen, H., Ouyang, L., & Wang, Y. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114094 · Cited by 53
Intrinsic Radiation Sensitivity: Cellular Signaling is the Key
Szumiel, I. (2008) · Radiation Research · doi:10.1667/rr1239.1 · Cited by 60
Kim, J. W., Im, S., Kim, M. A., Cho, H. J., Lee, D. W., Lee, K., Kim, T., Han, S., Oh, D., Lee, H., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28245 · Cited by 51
“ATM expression was classified into low ATM expression (2, 6, 1) and high ATM expression (11, 111) using immunohistochemistry analysis.”
BackgroundMethodInfluentialCharacterization of the DNA dependent activation of human ARTD2/PARP2
Obaji, E., Haikarainen, T., & Lehtiö, L. (2016) · Scientific Reports · doi:10.1038/srep34487 · Cited by 54
PARPing for balance in the homeostasis of poly(ADP-ribosyl)ation
Schuhwerk, H., Atteya, R., Siniuk, K., & Wang, Z. (2016) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.09.011 · Cited by 49
Muscle PARP1 inhibition extends lifespan through AMPKα PARylation and activation in Drosophila
Guo, S., Zhang, S., Zhuang, Y., Xie, F., Wang, R., Kong, X., Zhang, Q., Feng, Y., Gao, H., Kong, X., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2213857120 · Cited by 54
Sam68 Is Required for DNA Damage Responses via Regulating Poly(ADP-ribosyl)ation
Sun, X., Fu, K., Hodgson, A., Wier, E. M., Wen, M. G., Kamenyeva, O., Xia, X., Koo, L. Y., & Wan, F. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002543 · Cited by 47
“As DSB-induced ATM phosphorylation is known to rely on the activation of the DNA damage sensor PARP1 and subsequent PAR production [14,27], we examined PAR chain formation in γ-irradiated cells in the presence and absence of Sam68.”
BackgroundInfluentialPARP Inhibitors and Myeloid Neoplasms: A Double-Edged Sword
Csizmar, C. M., Saliba, A. N., Swisher, E. M., & Kaufmann, S. H. (2021) · Cancers · doi:10.3390/cancers13246385 · Cited by 45
“Similar results have since been observed with mutations in other DNA repair proteins, including ataxia telangiectasia mutated (ATM) [94] and members of the Fanconi anemia pathway [15].”
ResultInfluentialThe Role of hnRPUL1 Involved in DNA Damage Response Is Related to PARP1
Hong, Z., Jiang, J., Ma, J., Dai, S., Xu, T., Li, H. Z., & Yasui, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060208 · Cited by 46
“PARP1 is the first protein recruited to DNA damage sites and modulates ATM signaling pathway by poly(ADP-ribosyl)ation [27].”
BackgroundInteraction between PARP-1 and ATR in mouse fibroblasts is blocked by PARP inhibition
Kedar, P. S., Stefanick, D. F., Horton, J. K., & Wilson, S. H. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.07.006 · Cited by 48
Rao, A., Moka, N., Hamstra, D. A., & Ryan, C. J. (2022) · Cancers · doi:10.3390/cancers14030801 · Cited by 46
“%) followed by ATM, CHEK2, and BRCA1 (1.9, 1.6, and 0.9%, respectively) as the most frequent affected genes [46].”
BackgroundInfluentialZou, L.-H., Shang, Z., Tan, W., Liu, X.-D., Xu, Q.-Z., Song, M. S., Wang, Y., Guan, H., Zhang, S.-M., Yu, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3137 · Cited by 46
Understanding specific functions of PARP-2: new lessons for cancer therapy.
Ali, S. O., Khan, F. A., Galindo-Campos, M. A., & Yélamos, J. (2016) · RECERCAT (Consorci de Serveis Universitaris de Catalunya) · Cited by 61
The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest
Madison, D. L., Stauffer, D. R., & Lundblad, J. R. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.07.006 · Cited by 48
Wong, G. C., & Chow, H. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220203 · Cited by 48
“In ataxia telangiectasia (A-T) where the ATM gene that facilitates DSB repair is mutated, Purkinje neuron degeneration is found in all the patients, leading to cerebellar atrophy and ataxia [180].”
BackgroundFueling genome maintenance: On the versatile roles of NAD+ in preserving DNA integrity
Ruszkiewicz, J. A., Bürkle, A., & Mangerich, A. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102037 · Cited by 44
“Analogously, NR treatment stimulated neuronal DNA repair and improved mitochondrial quality in animal models of ataxia – telangiectasia, a disease linked to ATM de fi ciency.”
InfluentialHMGN1 Protein Regulates Poly(ADP-ribose) Polymerase-1 (PARP-1) Self-PARylation in Mouse Fibroblasts
Masaoka, A., Gassman, N. R., Kedar, P. S., Prasad, R., Hou, E. W., Horton, J. K., Bustin, M., & Wilson, S. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.370759 · Cited by 41
“PARP-1 is known to interact withATM, and PARylation of ATMaffects the phosphorylation cascade (53).”
Background(2015) · Journal of Cancer Sciences · doi:10.13188/2377-9292.1000009 · Cited by 40
Robert, I., Karicheva, O., Reina‐San‐Martin, B., Schreiber, V., & Dantzer, F. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.02.001 · Cited by 45
Gupta, M., Iyer, R. V., & Fountzilas, C. K. (2019) · Cancers · doi:10.3390/cancers11121980 · Cited by 43
“PARP1 has also implications in NHEJ and transcription modulation [34,35].”
BackgroundPoly(ADP-Ribose) Polymerase 1 Modulates the Lethality of CHK1 Inhibitors in Carcinoma Cells
Mitchell, C., Park, M., Eulitt, P. J., Chen, Y., Yacoub, A., & Dent, P. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.067199 · Cited by 40
“The inhibition of induced H2AX phosphorylation by PARP inhibition is probably explained by the requirement that ATM has for PARP1 function in being able to become activated after DNA damage and in our studies, knockdown of ATM blocked CHK1 inhibitorinduced H2AX phosphorylation (Haince et al., 2007).”
BackgroundImportance of PIKKs in NF-κB activation by genotoxic stress
Sabatel, H., Pirlot, C., Piette, J. G., & Habraken, Y. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.105 · Cited by 40
“(PARBM) allowing its anchorage to PARylated-PARP-1 [106,124].”
BackgroundInfluentialEarly histone H4 acetylation during chromatin remodeling in equine spermatogenesis†
Ketchum, C. C., Larsen, C. D., McNeil, A., Meyer‐Ficca, M. L., & Meyer, R. G. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox159 · Cited by 39
“PARP activity also negatively regulates the activities of TOP2B [13] and ATM [64, 65], buttressing the importance of DNA damage response pathways in the chromatin remodeling process that takes place in elongating spermatids.”
BackgroundInfluentialSadoughi, F., Mirsafaei, L., Dana, P. M., Hallajzadeh, J., Asemi, Z., Mansournia, M. A., Montazer, M., Hosseinpour, M., & Yousefi, B. (2021) · DNA repair · doi:10.1016/j.dnarep.2021.103074 · Cited by 40
Robinson, J. F., Griffith, W. C., Yu, X., Hong, S., Kim, E., & Faustman, E. M. (2010) · Reproductive Toxicology · doi:10.1016/j.reprotox.2010.05.009 · Cited by 36
“For example Parp1 and Trp53pb1 induce the DNA repair response by promoting stability of the p53 response through increased phosphorylation and inhibition of proteasomal degradation [41,42].”
BackgroundAtMMS21 regulates DNA damage response and homologous recombination repair in Arabidopsis
Yuan, D., Lai, J., Xu, P., Zhang, S., Zhang, J., Li, C., Wang, Y., Du, J., Liu, Y., & Yang, C. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.04.006 · Cited by 36
Characterization ofLGALS3(galectin-3) as a player in DNA damage response
Carvalho, R. S., Fernandes, V. C., Nepomuceno, T. C., Rodrigues, D. C., Woods, N. T., Suarez‐Kurtz, G., Chammas, R. J., Monteiro, Á. N. A., & Carvalho, M. A. (2014) · Cancer Biology & Therapy · doi:10.4161/cbt.28873 · Cited by 38
DNA‑PKcs PARylation regulates DNA‑PK kinase activity in the DNA damage response
Yang, H., Jin, F., Xie, Y., Liu, Y., Hu, S., Liu, X., Guan, H., Gu, Y., Ma, T., & Zhou, P. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10640 · Cited by 35
Orsburn, B. C., Escudero, B., Prakash, M., Gesheva, S. I., Liu, G., Huso, D. L., & Franco, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00091-10 · Cited by 38
Rabenau, K. E., & Hofstatter, E. W. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.06.006 · Cited by 34
Conceição, C. J. F., Moe, E., Ribeiro, P. A., & Raposo, M. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189282 · Cited by 43
Petersen, L. F., Klimowicz, A. C., Otsuka, S., Elegbede, A. A., Petrillo, S. K., Williamson, T. S., Williamson, C. T., Konno, M., Lees‐Miller, S. P., Hao, D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16215 · Cited by 32
Chromatin Composition Is Changed by Poly(ADP-ribosyl)ation during Chromatin Immunoprecipitation
Beneke, S., Meyer, K., Holtz, A. N., Hüttner, K., & Bürkle, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032914 · Cited by 32
“Next to the regulation of baseexcision repair, PAR is necessary for full activation of ATM [37] and recruitment of signal transmission factors [38].”
BackgroundHeritable sperm chromatin epigenetics: a break to remember†
Meyer, R. G., Ketchum, C. C., & Meyer‐Ficca, M. L. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox137 · Cited by 32
“Transient PAR/NAD+ turnover mediated by PARP1/2 and PARG activity after DNA strand breakage is critical for activation of the ATM signaling pathway, and absence of PARP activity impairs ATM/ATR phosphorylation [161, 162] (Figure 1b).”
BackgroundThe Ups and Downs of Tannins as Inhibitors of Poly(ADP-Ribose)glycohydrolase
Blenn, C., Wyrsch, P., & Althaus, F. R. (2011) · Molecules · doi:10.3390/molecules16021854 · Cited by 32
Wątroba, M., Maślińska, D., & Maśliński, S. (2012) · Advances in Medical Sciences · doi:10.2478/v10039-012-0039-1 · Cited by 34
Evaluation of the methods to identify patients who may benefit from PARP inhibitor use
Lim, D. G. S., & Ngeow, J. Y. Y. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0116 · Cited by 28
Advances in PARP Inhibitors for Prostate Cancer
Tisseverasinghe, S., Bahoric, B., Anidjar, M., Probst, S., & Niazi, T. M. (2023) · Cancers · doi:10.3390/cancers15061849 · Cited by 30
“Response rates per DDR gene defects were, respectively, 80% for BRCA1/2, 57% for PALB2, 37% for ATM, 25% for CDK12, and 20% for other identified genes.”
BackgroundInfluentialNakadate, Y., Kodera, Y., Kitamura, Y., Tachibana, T., Tamura, T., & Koizumi, F. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.134 · Cited by 31
Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair
Castaño, J., Herrero, A. B., Bursen, A., Gonzãlez, F., Marschalek, R., Gutierrez, N. C., & Menéndez, P. R. (2016) · Oncotarget · doi:10.18632/oncotarget.8938 · Cited by 27
“It has been very recently demonstrated that AML driven by repressive transcription factors, including AML1-ETO and PML-RARα are sensitive to poly (ADPribose) polymerase (PARP) inhibition, due to suppressed expression of HR-associated genes and impaired DDR associated to prevention of binding of KU proteins to DNA ends…”
BackgroundNEMO shuttle: A link between DNA damage and NF-κB activation in progeroid syndromes?
Salminen, A., Suuronen, T., Huuskonen, J., & Kaarniranta, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.189 · Cited by 27
“PARP-1 can also modulate the ATM kinase activity after DNA damage [29] and regulate the NEMO shuttle in this way.”
An assessment of poly (ADP‐ribose) polymerase‐1 role in normal and cancer cells
Kumar, M., Jaiswal, R. K., Yadava, P. K., & Singh, R. P. (2020) · BioFactors · doi:10.1002/biof.1688 · Cited by 27
“Haince et al. (2007) reported that DNA–PARP-1 complex activates ATM (ataxia telangiectasia mutated) kinase by its poly ADP-ribosylation.”
BackgroundInfluentialDesign, synthesis and antitumor activity study of PARP-1/HDAC dual targeting inhibitors
Chi, Z., Bai, Y., Li, J., Wang, K., Xu, Y., & Luan, Y. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128821 · Cited by 26
Sabisz, M., Węsierska‐Gądek, J., & Składanowski, A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.023 · Cited by 25
The biological activity of G-quadruplex DNA binding papaverine-derived ligand in breast cancer cells
Rubiś, B., Kaczmarek, M., Szymanowska, N., Gałęzowska, E., Czyrski, A., Juskowiak, B., Hermann, T., & Rybczyńska, M. (2008) · Investigational New Drugs · doi:10.1007/s10637-008-9173-9 · Cited by 26
“There is also another relevant group of potential anticancer agents, that are modulating the nucleic acid metabolism by Poly(ADP-ribose) polymerase, participating in DNA repair [ 1 ].”
BackgroundOpinion: PARP inhibitors in cancer—what do we still need to know?
Wicks, A. J., Krastev, D. B., Pettitt, S. J., Tutt, A. N. J., & Lord, C. J. (2022) · Open Biology · doi:10.1098/rsob.220118 · Cited by 27
“The activity of Ataxia telangiectasia mutated (ATM), a major activator of DSB repair pathways, is also controlled by an interaction with PAR chains [14,15].”
BackgroundClinically Applicable Inhibitors Impacting Genome Stability
Prakash, A., García-Moreno, J. F., Brown, J. A. L., & Bourke, E. (2018) · Molecules · doi:10.3390/molecules23051166 · Cited by 26
“2), contain PAR-binding domains, and interactions with PARP1 stimulate their activity [170,171].”
BackgroundCarrozza, M. J., Stefanick, D. F., Horton, J. K., Kedar, P. S., & Wilson, S. H. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.07.010 · Cited by 24
“ation plays a direct role in ATM activation [41].”
BackgroundBastos, I. F., Rebelo, S., & Silva, V. L. M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116045 · Cited by 30
Poly(ADP-ribosyl)ation affects stabilization of Che-1 protein in response to DNA damage
Bacalini, M. G., Lonardo, D. D., Catizone, A., Ciccarone, F., Bruno, T., Zampieri, M., Guastafierro, T., Calabrese, R., Fanciulli, M., Passananti, C., et al. (2011) · DNA repair · doi:10.1016/j.dnarep.2011.01.002 · Cited by 23
Bacalini, M. G., Tavolaro, S., Peragine, N., Marinelli, M., Santangelo, S., Giudice, I. D., Mauro, F. R., Maio, V. D., Ricciardi, M. R., Caiafa, P., et al. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.11.005 · Cited by 23
“PARP activity has recently been reported to promote the assembly of a signalosome complex that leads to activation of ATM [23] and nuclear factor-kB [24] signaling pathways after irradiation (IR); furthermore, poly(ADP-ribosyl)ation of p53 is necessary to allow its nuclear localization and thereafter its transactivati…”
BackgroundATM induces MacroD2 nuclear export upon DNA damage
Golia, B., Moeller, G. K., Jankevicius, G., Schmidt, A., Hegele, A., Preißer, J., Tran, M. L., Imhof, A., & Timinszky, G. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw904 · Cited by 22
MLH1 mediates PARP-dependent cell death in response to the methylating agent N-methyl-N-nitrosourea
McDaid, J. R., Loughery, J., Dunne, P. D., Boyer, J. C., Downes, C. S., Farber, R. A., & Walsh, C. P. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605186 · Cited by 22
“448 British Journal of Cancer (2009) 101(3), 441 – 451 & 2009 Cancer Research UK T ra n sla tio n a l T h e ra p e u tic s shown recently to physically and functionally interact following MNNG treatment (Haince et al, 2007).”
BackgroundInsights into the Possible Molecular Mechanisms of Resistance to PARP Inhibitors
Piombino, C., & Cortesi, L. (2022) · Cancers · doi:10.3390/cancers14112804 · Cited by 23
The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response
Brestovitsky, A., Nebenzahl-Sharon, K., Kechker, P., Sharf, R., & Kleinberger, T. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005420 · Cited by 24
“Potential examples of E4orf4-PP2A targets that could affect both ATM- and ATR-regulated pathways include the MRN complex which accumulates at DNA damage foci and initiates signaling involving activation of ATM and ATR kinases [6, 8, 75], PARP-1 which interacts with both ATM and ATR and parylates them [76, 77], or othe…”
BackgroundVeliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma
Buck, J. M., Dyer, P., Hii, H. L., Carline, B., Kuchibhotla, M., Byrne, J., Howlett, M., Whitehouse, J. P., Ebert, M. A., McDonald, K. L., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.633344 · Cited by 19
The Intra- and Extra-Telomeric Role of TRF2 in the DNA Damage Response
Imran, S. A. M., Yazid, M. D., Cui, W., & Lokanathan, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189900 · Cited by 19
“PARP1 will recruit other DDR factors at the site of DNA damage that will initiate the repair cascade [90,91].”
BackgroundGajewski, S., & Hartwig, A. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00130 · Cited by 19
Dual targeting, a new strategy for novel PARP inhibitor discovery
Wei, L., Wang, M., Wang, Q., & Han, Z. (2021) · Drug Discoveries & Therapeutics · doi:10.5582/ddt.2021.01100 · Cited by 18
“PARP can directly participate in the base resection repair pathway and repair single-stranded DNA gaps by activating ataxia telangiectasia mutated (ATM) to promote homologous recombination (HR) (8).”
BackgroundThakur, A., Rana, M., Ritika, Mathew, J., Nepali, S., Pan, C.-H., Liou, J. P., & Nepali, K. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106893 · Cited by 18
Węsierska‐Gądek, J., & Składanowski, A. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.175 · Cited by 17
Mass spectrometry-based functional proteomics of poly(ADP-ribose) polymerase-1
Pic, É., Gagné, J., & Poirier, G. G. (2011) · Expert Review of Proteomics · doi:10.1586/epr.11.63 · Cited by 19
Self-citationAssessment of PARP-3 Distribution in Tissues of Cynomolgous Monkeys
Rouleau, M., Elalfy, M., Lévesque, M.-H., & Poirier, G. G. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.953380 · Cited by 17
“GM00637 and C3ABR were cultured as described (Haince et al. 2007).”
MethodSelf-citationYamauchi, T., Uzui, K., Nishi, R., Shigemi, H., & Ueda, T. (2014) · PubMed · Cited by 17
Suh, K. J., Ryu, H. S., Lee, K.-H., Kim, H., Min, A., Kim, T., Yang, Y., Moon, H., Han, S., Oh, D., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3869-x · Cited by 17
“Moreover, the loss of function of the ATM gene has been considered a predictive marker for treatment with poly(ADP-ribose) polymerase (PARP)-1 inhibitors [10-13].”
BackgroundDrug Repurposing for Targeting Acute Leukemia With KMT2A (MLL)—Gene Rearrangements
Tsakaneli, A., & Williams, O. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.741413 · Cited by 19
Oh, K.-S., Nam, A., Bang, J., Seo, H.-R., Kim, J., Yoon, J., Kim, T., & Oh, D. (2022) · Oncogene · doi:10.1038/s41388-022-02384-w · Cited by 17
“Furthermore, it has also been demonstrated that ATM is a direct PAR binding targets, and PARdependent interaction between PARP1 and ATM is required for the recruitment of ATM to the DNA lesions for the proper downstream activation [33].”
BackgroundX-Ray Induced DNA Damage and Repair in Germ Cells of PARP1−/− Male Mice
Villani, P., Fresegna, A. M., Ranaldi, R., Eleuteri, P., Paris, L., Pacchierotti, F., & Cordelli, E. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140918078 · Cited by 20
“Due to the interplay between Ataxia Telangiectasia Mutated (ATM) kinase protein and poly(ADP-ribosyl)ation that is important for the phosphorylation of H2AX [51] a difference in the basal and radio-induced level of γ-H2AX foci could be expected between PARP1 −/−”
BackgroundKhadka, P., Hsu, J. K., Veith, S., Tadokoro, T., Shamanna, R. A., Mangerich, A., Croteau, D. L., & Bohr, V. A. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00427-15 · Cited by 17
“PAR formation plays a critical role in the rapid recruitment of DNA repair proteins such as MRE11 (12), NBS1 (13), BRCA1 (14), and ATM (15) to DSBs. Mice lacking PARP1 are extremely sensitive to genotoxic stresses, show defects in the repair of damaged DNA, and display genomic instability, with high frequencies of sis…”
BackgroundInfluentialDurmaz, İ., Jönsson, J.-M., & Hedenfalk, I. A. (2019) · Oncotarget · doi:10.18632/oncotarget.27363 · Cited by 16
ZNF432 stimulates PARylation and inhibits DNA resection to balance PARPi sensitivity and resistance
O’Sullivan, J., Kothari, C., Caron, M., Gagné, J., Jin, Z., Nonfoux, L., Beneyton, A., Coulombe, Y., Thomas, M. L., Atalay, N., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad791 · Cited by 15
“We have previously shown that PARylation can recruit the ATM kinase to sites of DNA damage ( 64 ) and many chromatin remodelling proteins have also been shown to be recruited in a PARP-dependent manner, driving chromatin de-condensation (recently reviewed in ( 65 ,66 )).”
BackgroundSelf-citationŠamanić, I., Cvitanić, R., Simunić, J., & Puizina, J. (2016) · Plant Biology · doi:10.1111/plb.12453 · Cited by 15
Matkarimov, B. T., Zharkov, D. O., & Saparbaev, M. K. (2019) · Mutagenesis · doi:10.1093/mutage/gez045 · Cited by 14
“The deposition of PAR at DSBs is likely involved in the efficient recruitment of ATM and MRE11, which both contain a functional PARbinding domain (42,46,47).”
BackgroundE1B and E4 oncoproteins of adenovirus antagonize the effect of apoptosis inducing factor
Turner, R. L., Wilkinson, J. C., & Ornelles, D. A. (2014) · Virology · doi:10.1016/j.virol.2014.03.010 · Cited by 17
“PARP-1 automodification and the localization of PAR at sites of DNA damage recruit DNA signaling and repair proteins and leads to PAR-modification of these proteins (Haince et al., 2007; Li and Yu, 2013; Sousa et al., 2012; Wang et al., 2012).”
BackgroundInhibiteurs de la PARP : des avancées significatives dans le traitement des cancers
Dantzer, F., Noël, G., & Schreiber, V. (2011) · Bulletin du Cancer · doi:10.1684/bdc.2011.1330 · Cited by 13
Current Overview on the Usage of Poly(ADP-ribose)polymerase (PARP) Inhibitors in Treating Cancer
Murahari, M., & Yergeri, M. C. (2014) · Clinical Cancer Drugs · doi:10.2174/2212697x01666140128002849 · Cited by 13
de Sousa, M. M. L., Bjørås, K. Ø., Hanssen‐Bauer, A., Solvang‐Garten, K., & Otterlei, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-06770-3 · Cited by 13
Mamar, H., Fajka‐Boja, R., Mórocz, M., Jurado, E. P., Zentout, S., Mihuț, A., Kopasz, A. G., Mérey, M., Smith, R., Sharma, A. B., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae439 · Cited by 14
“PARPi were reported to cause ATM activation ( 81 ,82 ).”
Kutuzov, M. M., Khodyreva, S. N., Schreiber, V., & Lavrik, O. I. (2014) · Molecular Biology · doi:10.1134/s0026893314040062 · Cited by 12
BRCAs, I., Durocher, F., Labrie, Y., Ouellette, G., & Simard, J. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0203-9 · Cited by 11
“suggests that ADPRT might act as a DNA damage sensor, playing a key role in early signaling of DNA damage (Haince et al. 2007).”
BackgroundGmPARPs differentially regulate the drought and heat stress tolerance in soybean
Tiwari, R., Singh, A. K., & Rajam, M. V. (2023) · Plant Growth Regulation · doi:10.1007/s10725-023-01047-4 · Cited by 12
“…chromatin remodelling, cell cycle, checkpoints, and DNA repair (Pleschke et al. 2000; Mendoza-Alvarez and Alvarez-Gon-zalez 2001; Chang et al. 2004; Haince et al. 2007; Aguilar-Quesada et al. 2007; Kanai et al. 2007; Kedar et al. 2008; Ahel et al. 2008, 2009; Gagné et al. 2008; Wang et al. 2009;…”
BackgroundLow Expression of ATM Indicates a Poor Prognosis in Clear Cell Renal Cell Carcinoma
Ren, W., Xue, B., Chen, M., Liu, L., & Zu, X. (2019) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2019.01.003 · Cited by 10
A Novel Reciprocal Crosstalk between RNF168 and PARP1 to Regulate DNA Repair Processes.
Kim, J. J., Lee, S. Y., Kim, S., Chung, J. M., Kwon, M., Yoon, J. H., Park, S., Hwang, Y., Park, D., Lee, J.-S., et al. (2018) · PubMed Central · doi:10.14348/molcells.2018.0078 · Cited by 10
“Intriguingly, it has also been reported that the PAR level is sustained in ATM-deficient cells (GM09607, GM03189), but not in control cells (Haince et al., 2007).”
BackgroundPoly(ADP-ribose) polymerase (PARP) inhibitors in BRCA1/2 cancer therapy
Kluzek, K., Białkowska, A., Koczorowska, A. M., & Zdzienicka, M. Z. (2012) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1000548 · Cited by 11
The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids
Somnay, Y. R., Lubner, S. J., Gill, H., Matsumura, J., & Chen, H. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.39 · Cited by 9
Regulation of DNA damage-induced ATM activation by histone modifications
Li, Z., Chen, Y., Tang, M., Li, Y., & Zhu, W. (2019) · Genome Instability & Disease · doi:10.1007/s42764-019-00004-8 · Cited by 9
Li, Y., Yang, C.-N., Kuo, M. Y., Lai, W.-T., Wu, T., & Lin, B. (2021) · Annals of Surgical Oncology · doi:10.1245/s10434-021-10322-5 · Cited by 9
Kato, M. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2015.10.021 · Cited by 8
Kim, Y., Kim, T., Park, S.-R., Kim, H.-T., Jung, D.-Y., Ryu, S., & Jung, J. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.12.004 · Cited by 8
“In ionizing radiation-induced DSB, ATM is activated by PARP-1, and PARP-1-deficient cells show defective ATM activity and DNA repair capacity (Aguilar-Quesada et al., 2007; Haince et al., 2007).”
BackgroundHybrid of DNA-targeting Chlorambucil with Pt(IV) Species to Reverse Drug Resistance
Chen, F., Xu, G., Qin, X., Jin, X., & Gou, S. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.243451 · Cited by 9
“(Haince et al., 2007).”
Neocarzinostatin, Aptamer Conjugates for Targeting EpCAM-positive Tumor Cells
Athyala, P. K., Kanwar, J. R., Chitipothu, S., KANWAR, R. K., Krishnakumar, S., Watson, J., & Janakiraman, N. (2017) · Anticancer Research · doi:10.21873/anticanres.11732 · Cited by 10
Morris, C., Durand, S., & Jalinot, P. (2021) · Oncotarget · doi:10.18632/oncotarget.27923 · Cited by 8
“In particular, PARP1 is involved in the early recruitment to DSB sites of the MRN complex and the ATM kinase, which both contain PAR-binding domains [6, 47].”
Backgroundul, M. T. ⁄., �etin, İ., Turan, S. Ï. ⁄. Z., & Kolusayın, M. Ö. (2018) · Oncology Reports · doi:10.3892/or.2018.6364 · Cited by 11
“Paclitaxel is commonly being used in several subtypes of cancer and a PARP inhibitor/PXL combination was suggested as an alternative therapeutic approach in various patient populations (26,27).”
"Yin-Yang" of PARP1 in genotoxic and inflammatory response
Wang, S., Wu, Y., Zong, W., & Wang, Z. (2025) · DNA repair · doi:10.1016/j.dnarep.2025.103858 · Cited by 7
Liang, Y., Li, Z., Tang, L., Pan, Z., Fei, X., Tan, C., He, A., Yang, Q., & Cheng, D. (2025) · Advanced Science · doi:10.1002/advs.202502926 · Cited by 11
Role of Apoptotic Proteins in REC‐2006 Mediated Radiation Protection in Hepatoma Cell Lines
Singh, P. K., Kumar, R., Sharma, A. K., Arora, R., Chawla, R., Jain, S. K., Tripathi, R. P., & Sharma, R. K. (2010) · Evidence-based Complementary and Alternative Medicine · doi:10.1093/ecam/neq059 · Cited by 7
Clinical Application of PARP1 Inhibitors and Challenges in Cancer Therapy
Luo, Y., Nie, M., Chen, Y., Huang, X., Cui, X., Lin, W., Xu, L., Li, E., & Cheng, Y. (2025) · Current Cancer Drug Targets · doi:10.2174/0115680096327635241021115944 · Cited by 6
Metadata
- Authors
- Haince, J.-F., Kozlov, S., Dawson, V. L., Dawson, T. M., Hendzel, M. J., Lavin, M. F., & Poirier, G. G.
- Affiliations
- Centre hospitalier universitaire de Québec (CA)
- QIMR Berghofer Medical Research Institute (AU)
- Johns Hopkins University (US)
- University of Alberta (CA)
- Corresponding author
- Poirier, Guy G.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 282
- Issue
- 22
- Pages
- 16441-16453
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2019775979
- Cited by
- 261
- References
- 61
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 4 · 2023: 9 · 2022: 13 · 2021: 12 · 2020: 6 · 2019: 13 · 2018: 10 · 2017: 18 · 2016: 16 · 2015: 20 · 2014: 21 · 2013: 18 · 2012: 20
- FWCI
- 6.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4873 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Institute of Neurological Disorders and Stroke (NS 39148, P01NS039148)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
- Keywords
- ATM kinase, poly(ADP-ribosyl)ation, PARP1, DNA damage response, p53 phosphorylation, H2AX phosphorylation, PARP inhibitors, chromatin remodeling, DNA repair, cell cycle checkpoints
- MeSH terms
- Poly (ADP-Ribose) Polymerase-1, Structural Maintenance of Chromosome Protein 1, Animals, Cell Line, Transformed, Chromosomal Proteins, Non-Histone, DNA Damage, DNA-Binding Proteins, Histones, Humans, Poly Adenosine Diphosphate Ribose, Poly(ADP-ribose) Polymerases, Protein Processing, Post-Translational, Signal Transduction, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Mice, Knockout, Cell Cycle Proteins, Tumor Suppressor Proteins, Chromatin Assembly and Disassembly, Cell Line, Tumor, Mice, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.